had entirely different results and still too asleep to add more info to the slide (I asked approximately how many patients were in each group, whether any were treated with herceptin(no), how many triple positive were treated with chemo in addition to hormonal therapy (those with positive lymph nodes or with other features which the European community agreed at San Gallen at the time(s)--which varied--indicated chemo should be added...and other features. Once I pull myself together I will try to add those...
http://www.abstracts2view.com/sabcs/...u=SABCS07L_409
And his average followup as I recall was only around 3.5 years, so the graph will need to be updated (when I asked he estimated in 2 years, not next year)
so patience is required. I urged him to continue to publish this data as frequently as possible, as treatment decisions which rely on perceived risk are being made daily without access to good data, as Adjuvant online does not include her2status